| Precision Trial |
Indicates whether the protocol uses precision medicine. |
Oncology: Required
Select 'Yes' if one of the following criteria is met:
- If the eligibility criteria for any treatment-specific portion of the trial requires a specific DNA or RNA alteration (e.g., amplification, deletion, fusion, mutation) that is either germline or somatic in order to be eligible for the study
- A non-treatment protocol designed to identify an actionable agent (DNA or RNA amplification, deletion, fusion or mutation) in order to identify subjects as potential eligible for another treatment trial.
Note: For studies that stratify patients based on a mutation status to be present or absent in order to be eligible for the trial, the precision question should be answered 'No'.
Non-oncology: Not required |
PC Console edit / Protocol Coordinator |
No |
